Identifying Skin Biopsy Sites

Identification of Skin Cancer Biopsy Sites Clinical Trial

Official title:

Pilot Study of Skin Biopsy Sites: A Consensus Approach Based on Patient and Physician Interviews

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01632644
• Other study ID #: STU66384
• Status: Completed
• Start date: July 2012
• Est. completion date: May 2013

Study information

• Verified date: December 2021
• Source: Northwestern University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The primary objective of this study is to investigate the patient experience during skin biopsy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 59
• Est. completion date: May 2013
• Est. primary completion date: May 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18 and Over

• The subjects are in good health.

• The subjects have the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.

• Patients who have had one or multiple skin biopsies OR board-certified dermatologists.

Exclusion Criteria:

• Under 18 years of age.

• Subjects who are unable to understand the protocol or give informed consent.

Related Conditions & MeSH terms

• Identification of Skin Cancer Biopsy Sites
• Skin Neoplasms

Intervention

Other:
• Survey/Interview
Each group will be surveyed and interviewed.

Locations

Country	Name	City	State
United States	Northwestern University Dermatology	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Review of Physician and Patient Experience	Subjects will answer a combination of: Open-ended questions and; Questions asking for subject to rank possible responses	Last four weeks of study
Secondary	Physician's Experience with Skin Biopsy Sites	Physicians will answer a combination of: Open-ended questions, and; Questions asking for subject to rank possible responses	First four weeks of study
Secondary	Patient's Experience with Skin Biopsy Sites	Patients will answer a combination of: Open-ended questions and; Questions asking for subject to rank possible responses	First four weeks of study